tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market
Holding NGNE?
Track your performance easily

Neurogene (NGNE) Financial Statements

466 Followers

Neurogene Financial Overview

Neurogene's market cap is currently ―. The company's EPS TTM is $-4.493; its P/E ratio is -3.83; Neurogene is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-$ 925.00K---
Gross Profit-$ 925.00K---
EBIT$ -20.21M$ -18.49M$ -16.92M$ -28.89M$ -3.48M
EBITDA$ -19.40M$ -17.23M$ -16.55M$ -25.15M$ -2.44M
Net Income Common Stockholders$ -20.22M$ -18.49M$ -16.92M$ -5.73M$ -4.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 138.99M$ 153.91M$ 169.53M$ 197.16M$ 78.51M
Total Assets$ 164.12M$ 179.82M$ 195.35M$ 222.57M$ 89.59M
Total Debt$ 13.12M$ 13.79M$ 14.41M$ 14.97M$ 10.69M
Net Debt$ -125.87M$ -140.12M$ -155.13M$ -182.19M$ -67.81M
Total Liabilities$ 26.71M$ 24.81M$ 24.57M$ 36.55M$ 14.35M
Stockholders Equity$ 137.41M$ 155.01M$ 170.78M$ 186.02M$ 75.23M
Cash Flow-
Free Cash Flow$ -15.77M$ -16.26M$ -21.77M$ -31.93M$ -4.27M
Operating Cash Flow$ -15.60M$ -15.80M$ -21.70M$ -30.07M$ -4.27M
Investing Cash Flow$ -28.97M$ -23.61M$ 29.93M$ 16.96M$ -1.61M
Financing Cash Flow$ 131.00K$ 399.00K$ -6.52M$ 92.84M$ -1.00K
Currency in USD

Neurogene Earnings and Revenue History

Neurogene Debt to Assets

Neurogene Cash Flow

Neurogene Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis